Strides Pharma Science Ltd - Share Price
STAR
Strides Pharma Science LtdFinancials
Strides Pharma Science LtdNews & Updates
Strides Pharma Science receives upgrade in LT Issuer Rating
Jan 22,2021 09:03 AM
From India Ratings and Research
USFDA approves Strides Pharma's Emtricitabine and Tenofovir Disoproxil Fumarate tablets Jan 15,2021
Strides Pharma gains after getting USFDA approval Jan 15,2021
Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets Jan 15,2021
Aditya Puri joins as Advisor to the Strides Group and Director of Stelis Biopharma Jan 08,2021
Aditya Puri joins Strides Group as advisor Jan 08,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 575.20 | 47.88 | 137,973.76 | 724.81 | 0.70 | 3,207.24 | 106.10 |
| Divis Laboratories Ltd | 3,544.70 | 53.52 | 94,092.68 | 513.30 | 0.45 | 1,713.78 | 313.47 |
| Dr Reddys Laboratories Ltd | 5,036.90 | 34.09 | 83,711.25 | 481.00 | 0.50 | 3,333.60 | 979.38 |
| Cipla Ltd | 808.30 | 29.06 | 65,166.04 | 745.64 | 0.49 | 3,711.03 | 233.61 |
| Aurobindo Pharma Ltd | 923.80 | 20.34 | 54,120.22 | 801.54 | 0.32 | 4,425.43 | 246.88 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Strides Pharma Science LtdSummary & Reports
Strides Pharma Science Limited is an integrated manufacturer and exporter of finished pharmaceutical dosage forms for both branded and generic. The company manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals. Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semi-solids. They undertake contract research and manufacturing of specialty chemicals. ... More
Registered Office
No 201 Devavrata Sector 17,Vashi,Navi Mumbai, Maharashtra,400703
Tell. : +91-22-27892924/27893199
Website : http://www.stridesarco.com
Email : investors@stridesshasun.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com
Reports by strides-pharma-science-ltd-share-price
Latest Release by strides-pharma-science-ltd-share-price
Result Express
Jan 24, 2021 10:01 PM
The company’s consolidated revenue stood at Rs794.50cr, up 6.07% yoy and 8.44% qoq.
Shareholding Snapshot
Loading ...
| Dec - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.21% |
| Indian | 29.48% |
| Total Promoter | 29.69% |
| Non Promoter | - |
| Institutions | 41.81% |
| Non-Institutions | 28.50% |
| Total Non-Promoter | 70.31% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
29 Oct 2020
Annc. Date
23 Oct 2020
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company... More
Purpose
AGM
Exp. Date
20 Aug 2020
Annc. Date
16 Jul 2020
AGM 20/08/2020Newspaper advertisement titled 29th Annual General Meeting to be held over video confe... More
